USPTO serial 79135579
DUOBODY
Reviewed by CopyMark Law Group
Reg. 4582290Status 709
- Filing date
- Status date
- Registration date
- Aug 12, 2014
- Examiner
- BULLOFF, TOBY ELLEN
- Law office
- GENERIC WEB UPDATE
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with DUOBODY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Max Vern
Max Vern AMSTER, ROTHSTEIN & EBENSTEIN LLP405 Lexington AvenueNew York, NY 10174United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Chemical, ] biochemical, biological and biotechnological preparations, especially antibodies, and bi and multi specific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these, all for vitro and in vivo scientific and industrial research and development with regard to diseases | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical [ and veterinary ] preparations, namely, pharmaceutical preparations based on antibodies, bi and multispecific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to treatment of cancer, infectious diseases, immune and autoimmune diseases, inflammatory diseases, neurodegenerative diseases and cardiovascular diseases | SECTION 71 - CANCELLED | — |
| 042 | Medical, scientific and biological research, especially research into antibodies and bi and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies and bi and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these; chemical analysis; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy, including scientific research, development and therapy with antibodies, bi and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these | SECTION 71 - CANCELLED | — |
| 045 | Legal services in the form of patent exploitation and licensing of intellectual property in the field of medicines | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Genmab A/S
- Other trademarks owned by Genmab A/S
- Other trademarks owned by Genmab A/S
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named DUOBODY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 6, 2026 | C71T | CANCELLED SECTION 71 | — |
| Mar 21, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 5, 2024 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jun 5, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 5, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 5, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 5, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 5, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 15, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Aug 12, 2023 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Apr 7, 2023 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Dec 25, 2021 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Nov 14, 2021 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Nov 14, 2021 | INPC | INVALIDATION PROCESSED | — |
| Oct 24, 2021 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 24, 2021 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Feb 24, 2021 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Feb 23, 2021 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 3, 2021 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Oct 26, 2017 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 8, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 20, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 9, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 9, 2017 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 27, 2016 | PRA7 | REGISTERED - SEC. 7 REQUEST ABANDONED | — |
| Feb 13, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 27, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 27, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 12, 2014 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 22, 2014 | PRAM | POST REGISTRATION ACTION MAILED - SEC. 7 | — |
| Sep 14, 2014 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 4, 2014 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Aug 12, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 27, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 23, 2014 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 7, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 7, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 7, 2014 | NPUB | NOTICE OF PUBLICATION | — |
| Apr 24, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 24, 2014 | ALIE | ASSIGNED TO LIE | — |
| Apr 3, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 2, 2014 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Apr 2, 2014 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 2, 2014 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 24, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 24, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 24, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 16, 2013 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 24, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 23, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 23, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 21, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 20, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 19, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 18, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 13, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |